New Jersey: Hackensack Meridian Health's New Myeloma Institute
The team at Hackensack Meridian Health, part of New Jerseys largest and most comprehensive healthcare network, recently announced the opening of the Institute for Multiple Myeloma. The Institute will be located in a state-of-the art research facility at the Hackensack Meridian Health Interprofessional Health Sciences Campus in Nutley and Clifton, NJ, and led by founding director, David Siegel, M.D., Ph. D. Dr. Siegel is also chief of the Multiple Myeloma Division at John Theurer Cancer Center at Hackensack University Medical Center.
Under the leadership of Dr. Siegel, and alongside hematology experts like André Goy, MD, MS, chairman and executive director, division chief of Lymphoma, John Theurer Cancer Center, the Institute will focus on driving innovative research, and continuing the development of precision medicine for each patient. The John Theurer Cancer Center currently is running studies including CAR T-cells, NK-cell based therapies, and Bone Marrow Transplantation.
The John Theurer Cancer Center at Hackensack University Medical Center has built one of the worlds largest multiple myeloma programs, with more than 2,000 patients on active therapy John Theurer Cancer Center and Georgetown Lombardi Comprehensive Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, established a research partnership. This strategic collaboration has allowed the two institutions to leverage resources, capabilities, and expertise to accelerate discoveries in cancer research and clinical care. The combined strength also sparks collaborations with other academic cancer centers as well as the pharmaceutical industry. The shared goal of the research collaboration fosters combined leadership in basic cancer research and clinical care for the betterment of their patients. (Hackensack Meridian Health, 2018)
The Institute for Multiple Myeloma is part of Hackensack Meridian Healths Center for Discovery and Innovation, which has plans to open two additional centers, the Institute for Regenerative Medicine, and the Institute for Cancer and Infectious Diseases.
For more information about the Institute for Multiple Myeloma and the John Theurer Cancer Center, you can visit the website.
Hackensack Meridian Health. (2018, August 7). Hackensack Meridian Health Celebrates Opening of the Institute for Multiple Myeloma [Press Release] Retrieved from https://www.hackensackmeridianhealth.org/2018/08/07/hackensack-meridian-health-celebrates-opening-institute-multiple-myeloma/
The team at Hackensack Meridian Health, part of New Jerseys largest and most comprehensive healthcare network, recently announced the opening of the Institute for Multiple Myeloma. The Institute will be located in a state-of-the art research facility at the Hackensack Meridian Health Interprofessional Health Sciences Campus in Nutley and Clifton, NJ, and led by founding director, David Siegel, M.D., Ph. D. Dr. Siegel is also chief of the Multiple Myeloma Division at John Theurer Cancer Center at Hackensack University Medical Center.
Under the leadership of Dr. Siegel, and alongside hematology experts like André Goy, MD, MS, chairman and executive director, division chief of Lymphoma, John Theurer Cancer Center, the Institute will focus on driving innovative research, and continuing the development of precision medicine for each patient. The John Theurer Cancer Center currently is running studies including CAR T-cells, NK-cell based therapies, and Bone Marrow Transplantation.
The John Theurer Cancer Center at Hackensack University Medical Center has built one of the worlds largest multiple myeloma programs, with more than 2,000 patients on active therapy John Theurer Cancer Center and Georgetown Lombardi Comprehensive Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, established a research partnership. This strategic collaboration has allowed the two institutions to leverage resources, capabilities, and expertise to accelerate discoveries in cancer research and clinical care. The combined strength also sparks collaborations with other academic cancer centers as well as the pharmaceutical industry. The shared goal of the research collaboration fosters combined leadership in basic cancer research and clinical care for the betterment of their patients. (Hackensack Meridian Health, 2018)
The Institute for Multiple Myeloma is part of Hackensack Meridian Healths Center for Discovery and Innovation, which has plans to open two additional centers, the Institute for Regenerative Medicine, and the Institute for Cancer and Infectious Diseases.
For more information about the Institute for Multiple Myeloma and the John Theurer Cancer Center, you can visit the website.
Hackensack Meridian Health. (2018, August 7). Hackensack Meridian Health Celebrates Opening of the Institute for Multiple Myeloma [Press Release] Retrieved from https://www.hackensackmeridianhealth.org/2018/08/07/hackensack-meridian-health-celebrates-opening-institute-multiple-myeloma/
about the author
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation.
More on Treatment Advances
Trending Articles
Upcoming Events
Sign Up for Exclusive Multiple Myeloma Updates & Resources.
By subscribing to the Healthtree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.